Innoviz Technologies (NASDAQ: INVZ) grants CFO share options and RSUs
Rhea-AI Filing Summary
Innoviz Technologies Chief Financial Officer Eldar Mordechay Cegla reported equity compensation grants dated August 4, 2026. He received 78,416 share options with a $0.42 exercise price expiring on August 4, 2033 and 73,184 RSUs, both vesting one-fourth on August 4, 2027 with the remainder vesting quarterly through 2030, subject to continued service. After these awards, he is reported as holding 537,237 ordinary shares, including 234,628 shares issuable upon vesting of RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 73,184 shares
Net Buy
2 txns
Insider
Cegla Eldar Mordechay
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option F4 | 78,416 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F1, F2, F3 | 73,184 | $0.00 | $0.00 |
Holdings After Transaction:
Share Option — 78,416 shares (Direct);
Ordinary Shares — 537,237 shares (Direct)
Footnotes (4)
- F1. Represents 73,184 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
- F2. Includes 234,628 ordinary shares issuable upon vesting of RSUs; of which (a) 2,607 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 11,104 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 13,109 RSUs granted February 27, 2024, with 2,616 vesting quarterly through 2027 and 10,493 vesting quarterly through 2028; (d) 25,524 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 15,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,016 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 73,184 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.
- F3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
- F4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
Key Figures
Share options granted: 78,416 options
Option exercise price: $0.42 per share
Option expiration date: August 4, 2033
+3 more
6 metrics
Share options granted
78,416 options
Share options granted to the CFO on August 4, 2026
Option exercise price
$0.42 per share
Exercise price of the 78,416 share options granted August 4, 2026
Option expiration date
August 4, 2033
Expiration of the newly granted share options
RSUs granted
73,184 RSUs
Restricted Share Units granted to the CFO on August 4, 2026
Shares following awards
537,237 shares
Ordinary shares reported as directly held after the August 4, 2026 grants
RSU-linked shares
234,628 shares
Ordinary shares issuable upon vesting of RSUs included in post-transaction holdings
Key Terms
Restricted Share Units (RSUs), exercise price, vesting
3 terms
exercise price financial
"No exercise price is applicable. Share options have a $0.42 exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Innoviz (INVZ) grant to its CFO on August 4, 2026?
Innoviz granted CFO Eldar Mordechay Cegla 78,416 share options at a $0.42 exercise price and 73,184 RSUs on August 4, 2026. These are compensation awards, not open-market purchases, and are structured to vest over several years through 2030.
What is the size and vesting structure of the 73,184 RSUs granted by Innoviz (INVZ)?
The CFO was granted 73,184 Restricted Share Units (RSUs), each representing a right to one ordinary share with no exercise price. One-fourth vests on August 4, 2027, with the remaining RSUs vesting quarterly through 2030, subject to continued service.
Are the Innoviz (INVZ) equity awards to the CFO subject to continued service conditions?
Yes. Both the 73,184 RSUs and 78,416 share options vest only if the CFO remains a service provider on each vesting date. Footnotes specify that vesting through 2030 is contingent on ongoing service with Innoviz Technologies.